Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Approved For Marketing No phase listed Expanded access

An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors

ClinicalTrials.gov ID: NCT03154437

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03154437. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 20, 2026, 4:17 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multicenter, Expanded Access Program for Emicizumab in Patients With Hemophilia A With Inhibitors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This open-label, multicenter expanded access program (EAP) is designed to provide emicizumab to eligible participants with hemophilia A with factor VIII (FVIII) inhibitors before it is commercially available in the United States for the indication of hemophilia A with FVIII inhibitors. Discontinuation may occur earlier if participant or physician decides to discontinue treatment or the sponsor discontinues emicizumab clinical development.

Study identification

NCT ID
NCT03154437
Recruitment status
Approved For Marketing
Study type
Expanded access
Phase
Not listed
Lead sponsor
Genentech, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Mar 29, 2018

United States locations

U.S. sites
14
U.S. states
13
U.S. cities
14
Facility City State ZIP Site status
University of Colorado Denver, Children's Hospital Aurora Colorado 80045 —
University of Miami Miller School of Medicine Miami Florida 33136 —
Rush Medical Center Chicago Illinois 60612 —
Tulane Medical Center; Investigational/Research Pharmacy New Orleans Louisiana 70112 —
Boston Childrens Hospital Boston Massachusetts 02115 —
University of Minnesota Minneapolis Minnesota 55455 —
Children's Mercy Hosp Clinics Kansas City Missouri 64108 —
Barnabas Health Newark Beth Israel Medical Center - Pulmonary Hypertension & Lung Transplant Program Newark New Jersey 07112 —
Nationwide Children's Hospital Columbus Ohio 43205 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
University of Texas Southwestern Medical Center - Children's Medical Center Dallas Dallas Texas 75235 —
University of Texas Medical School Houston Texas 77030 —
University of Utah Salt Lake City Utah 84132 —
Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03154437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2018 · Synced Nov 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.